Home Search
omalizumab - search results
If you're not happy with the results, please do another search
Study: Omalizumab (Xolair) May Help Treat Idiopathic Anaphylaxis
Small study finds drug may be effective in treating IA.
Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food Allergies
Patients reached full tolerance for 70.4% of the tested foods which were reintroduced to the patients’ diet without the need for OIT.
FDA Approves Xolair for Children and Adults With One or More Food Allergies
A significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placebo.
FDA Grants Xolair Priority Review for Children and Adults with Food Allergies
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure.
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3 Trial
Assessment for both single agent and add-on therapy.
United Biopharma’s Monoclonal Antibody Shows Promise in Neutralizing IgE
Shows promise for the treatment of chronic spontaneous urticaria, food allergies, asthma and eczema.
Halsey Diagnosed with Mast Cell Activation Syndrome and a Host of Other Ailments. What...
Singer hospitalized for anaphylaxis numerous times.
Making the Impossible, Possible: Redefining How Peanut Allergies are Diagnosed (Sponsored)
Never before has a blood test been able to help you make the decisions you face every single day living with food allergies.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple Foods
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
OIT is a Therapy, Not an Ideology
The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
Copyright ©2011-2024 SnackSafely.com, Inc — All rights reserved